Hyderabad Telangana, India

Krishna Reddy Valluru

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 16.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: **Innovative Contributions of Inventor Krishna Reddy Valluru**

Introduction

Krishna Reddy Valluru, an accomplished inventor based in Hyderabad, Telangana, holds two patents that reflect his significant contributions to the field of therapeutic compounds. His work focuses on innovative methods for treating disorders such as schizophrenia and cognitive deficits, utilizing advanced chemical compounds.

Latest Patents

Valluru's latest patents detail methods of treating disorders by modulating striatal-enriched tyrosine phosphatase (STEP). The first patent focuses on therapeutic compounds designed for treating circumstances, including schizophrenia and cognitive deficits, employing compounds of specific chemical formulas. The second patent elaborates on pharmaceutical compositions that contain these compounds, which include quinoline and quinazoline derivatives. These compounds play a crucial role in mitigating the effects of the target disorders by enhancing STEP activity.

Career Highlights

Currently engaged with Otsuka Pharmaceutical Company, Limited, Valluru has made impactful strides in pharmacological research. His innovative approach includes a strong emphasis on the application of therapeutic compounds for mental health disorders. His work at Otsuka Pharmaceutical reflects his dedication to improving treatment options for patients suffering from complex neurological conditions.

Collaborations

Valluru collaborates closely with esteemed colleagues Masaki Suzuki and Kazumi Kondo. Together, they contribute to the innovative environment at Otsuka Pharmaceutical, facilitating advancements in treatment methodologies and therapeutic development.

Conclusion

Krishna Reddy Valluru exemplifies the spirit of innovation in the pharmaceutical industry. With his focus on therapeutic compounds targeting cognitive disorders, he contributes valuable knowledge and technology that can significantly improve patients' lives. His patents not only highlight his inventive capabilities but also underscore the importance of collaborative efforts in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…